logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

SF REIT (02191): Lam Chung Chi appointed as Deputy Chief Executive Officer of the property trust manager

date
17:36 26/11/2025
avatar
GMT Eight
Shunfeng Real Estate Investment Trust (02191) announced that Mr. Lin Congzhi (Mr. Lin) has been appointed as the Deputy Chief Executive Officer of the Real Estate Investment Trust manager...
SF REIT (02191) announced that Mr. Lam Chung Chi (Mr. Lam) has been appointed as the Deputy Chief Executive Officer of the property trust manager, effective from December 1, 2025.
Related Articles
HK Stock
VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.
China Stock
Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.
China Stock
Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."
VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.
HK Stock
Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.
China Stock
Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."
China Stock
RECOMMEND
Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
icon
25/11/2025
Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
icon
25/11/2025
Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
icon
25/11/2025
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.